He is also faculty in Radiology and Pharmacology in Weill Cornell Medical College. His NIH and DoD funded Lab focuses on the development of novel and innovative imaging and therapy approaches for cancer diagnostics, such as e.g. Cerenkov Imaging. His lab was the first to utilize PET tracers clinically for Cerenkov imaging and is developing new approaches for this novel modality His lab strives to develop novel concepts on how to image biological events. This includes understanding the biological basis while simultaneously keeping clinical translatability of the projects within sight.
As an expert in the field of nanotechnology and a radiologist with experience in both clinical radiology and basic science, Dr. Grimm received his medical degree from the University of Hamburg and his PhD from the University of Schleswig-Holstein, both located in Germany. He was a postdoctoral fellow and later faculty in the Center for Molecular Imaging research at Massachusetts General Hospital in Boston from 2002-2006. Dr. Grimm has authored numerous articles, reviews and book chapters. He was also a speaker at countless seminars, lectures and symposia. He received the NIBIB Edward Nagy New Investigator Award (2014) from the NIH and was elected Member of the American Society for Clinical Investigation in 2018.
Dr. Grimm’s clinical focus is on body and nuclear imaging. He is board certified in Radiology (German and US certification) and Nuclear Medicine (in the US).

His interest is in developing microfluidic and wearable technologies for biomedical applications. He has authored over 400 peer-reviewed journal publications. He is an elected Fellow of AIMBE, IAMBE and the Academy of Engineering, Singapore. Prof Lim has co-founded six spin-offs. He and his team have garnered over 100 research honors and awards including Highly Cited Researcher 2019, ASEAN Outstanding Engineering Achievement Award 2016, Credit Suisse Technopreneur of the Year Award and Wall Street Journal Asian Innovation Award (Gold) 2012 and President's Technology Award 2011.

She joined NUS in late 2005, where she is currently the Provost’s Chair Professor, Head of Department of Chemical and Biomolecular Engineering, and Vice President in Research and Technology. For her research focusing on organic nanomaterials for biomedical and energy applications, Prof. Liu has received many highly prestigious awards, including Singapore President’s Technology Award 2016, and Asian Scientist Top 100 List in 2017, Micro-Nano Letters Researcher Award in 2018, ACS Nano Lectureship Award in 2019. Prof. Liu was named as the Top 1% Highly Cited Researchers in Materials Science by Thomson Reuters and Clarivate Analytics from 2014 to 2019. She is the Fellow of Singapore Academy of Engineering, Asia-Pacific Academy of Materials, and the Royal Society of Chemistry.

She started her independent career at Case Western Reserve University School of Medicine; before that she trained at The Scripps Research Institute, La Jolla, CA; and she obtained her PhD in Bionanotechnology from the University of East Anglia where she prepared her dissertation at the John Innes Centre, Norwich, UK. Her early training was at the RWTH-Aachen University in Germany. Dr. Steinmetz has authored more than 150 journal articles. Dr. Steinmetz is a standing member of the NIH Nanotechnology study section.  She serves on the Editorial Board of Wiley Interdisciplinary Reviews (WIREs) on Nanomedicine and Nanobiotechnology; she serves on the Advisory Editorial Board for ACS Nano, Molecular Pharmaceutics and Journal of Materials Chemistry B. Dr. Steinmetz is a Fellow of the Royal Society of Chemistry and a Fellow the American Institute of Medical and Biological Engineering.

In 2007, Prof. Thurecht was simultaneously awarded a Ramsay Centenary Fellowship and 1851 Research Fellowship in the UK, and has since held both an ARC Australian Postdoctoral Fellowship (2008) and an ARC Future Fellowship (2012). In 2015, Prof. Thurecht was awarded the RACI David Sangster Polymer Science and Technology Award from the Polymer Division. Prof. Thurecht is acting Deputy Director (Research Technologies)  within the Centre for Advanced Imaging (CAI) and a senior group leader at the Australian Institute for Bioengineering and Nanotechnology (AIBN) at the University of Queensland where he currently holds an NHMRC Career Development Fellowship (CDF2). His research focusses on developing improved understanding of the nano-bio interface, particularly using molecular imaging tools to address some of the complex questions in this field.  His team works across the boundaries of chemistry and materials, biology and imaging science to probe how nanomaterial properties affect their function in living animals. He is theme leader in the ARC Training Centre for Innovation in Biomedical Imaging and Technology.